bankruptcy

Rosetta had disclosed that it intended to file for bankruptcy after its merger with Genoptix was not completed as planned.

The company is developing tests based on the analysis of the spatial patterns of chromosomes by tagging and imaging their telomeres.

Genoma, which is based in Italy, offers a wide range of specialty diagnostics services with an emphasis on noninvasive prenatal testing, as well as oncology tests. 

The UK-based firm said that it "will vigorously pursue all options to recover the debt or equivalent assets."

Nuclea's trustee has requested the court approve sale of its assets, which failed to sell at auction, to a firm run by Nuclea's former CEO Patrick Muraca.

True Health made its bid last week in an auction, increasing it from an original $32 million in order to beat out other potential buyers.

True Health will pay $37.1 million to acquire substantially all the assets of Health Diagnostic Laboratory, which is currently in Chapter 11 reorganization.